Hubei Guangji Pharmaceutical Co Ltd (000952) — Financial Flexibility Index
Hubei Guangji Pharmaceutical Co Ltd (000952) has a Financial Flexibility Index of 0.02x as of September 2025. Free cash flow of CN¥31.05 Million (operating CF CN¥22.38 Million minus capex CN¥8.67 Million) represents 0% of total liabilities (CN¥1.62 Billion). Check asset allocation strategy of Hubei Guangji Pharmaceutical Co Ltd to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Hubei Guangji Pharmaceutical Co Ltd Financial Flexibility Index (1998–2025)
Historical Financial Flexibility Index trend for Hubei Guangji Pharmaceutical Co Ltd across 28 annual periods. See working capital position of Hubei Guangji Pharmaceutical Co Ltd to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Hubei Guangji Pharmaceutical Co Ltd (1998–2025)
Year-by-year free cash flow to debt coverage for Hubei Guangji Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see Hubei Guangji Pharmaceutical Co Ltd market capitalisation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.06x | CN¥96.07 Million | CN¥60.43 Million | CN¥1.69 Billion | ▼ -37.1% |
| 2024 | 0.09x | CN¥155.59 Million | CN¥655.36K | CN¥1.72 Billion | ▼ -64.4% |
| 2023 | 0.25x | CN¥417.17 Million | CN¥-148.96 Million | CN¥1.64 Billion | ▲ +0.1% |
| 2022 | 0.25x | CN¥248.79 Million | CN¥45.08 Million | CN¥977.25 Million | ▼ -11.7% |
| 2021 | 0.29x | CN¥172.51 Million | CN¥75.91 Million | CN¥598.09 Million | ▼ -18.5% |
| 2020 | 0.35x | CN¥217.27 Million | CN¥119.38 Million | CN¥613.75 Million | ▲ +7.6% |
| 2019 | 0.33x | CN¥263.96 Million | CN¥144.20 Million | CN¥802.21 Million | ▼ -13.2% |
| 2018 | 0.38x | CN¥307.97 Million | CN¥231.44 Million | CN¥812.33 Million | ▲ +28.0% |
| 2017 | 0.30x | CN¥259.74 Million | CN¥178.83 Million | CN¥876.65 Million | ▲ +3.1% |
| 2016 | 0.29x | CN¥280.02 Million | CN¥167.07 Million | CN¥974.70 Million | ▲ +315.2% |
| 2015 | 0.07x | CN¥76.59 Million | CN¥-33.35 Million | CN¥1.11 Billion | ▲ +273.8% |
| 2014 | 0.02x | CN¥19.94 Million | CN¥-74.69 Million | CN¥1.08 Billion | ▼ -89.6% |
| 2013 | 0.18x | CN¥145.20 Million | CN¥95.16 Million | CN¥816.78 Million | ▼ -37.2% |
| 2012 | 0.28x | CN¥225.48 Million | CN¥108.02 Million | CN¥795.93 Million | ▼ -35.6% |
| 2011 | 0.44x | CN¥282.84 Million | CN¥81.88 Million | CN¥643.07 Million | ▲ +24.4% |
| 2010 | 0.35x | CN¥192.74 Million | CN¥77.18 Million | CN¥545.06 Million | ▲ +37.1% |
| 2009 | 0.26x | CN¥125.58 Million | CN¥-24.35 Million | CN¥486.93 Million | ▼ -76.8% |
| 2008 | 1.11x | CN¥440.46 Million | CN¥220.70 Million | CN¥395.78 Million | ▼ -4.8% |
| 2007 | 1.17x | CN¥380.92 Million | CN¥331.98 Million | CN¥325.76 Million | ▲ +148.4% |
| 2006 | 0.47x | CN¥144.68 Million | CN¥125.95 Million | CN¥307.34 Million | ▲ +106.4% |
| 2005 | 0.23x | CN¥79.98 Million | CN¥54.14 Million | CN¥350.68 Million | ▲ +100.3% |
| 2004 | 0.11x | CN¥44.27 Million | CN¥-3.32 Million | CN¥388.76 Million | ▼ -20.3% |
| 2003 | 0.14x | CN¥50.34 Million | CN¥-15.40 Million | CN¥352.38 Million | ▼ -64.7% |
| 2002 | 0.40x | CN¥126.72 Million | CN¥76.20 Million | CN¥313.05 Million | ▲ +355.4% |
| 2001 | 0.09x | CN¥24.44 Million | CN¥-22.40 Million | CN¥274.96 Million | ▼ -76.5% |
| 2000 | 0.38x | CN¥73.67 Million | CN¥48.57 Million | CN¥194.67 Million | ▼ -63.0% |
| 1999 | 1.02x | CN¥204.15 Million | CN¥68.57 Million | CN¥199.49 Million | ▲ +1650.4% |
| 1998 | -0.07x | CN¥-12.33 Million | CN¥-15.29 Million | CN¥186.80 Million | — |